Raptor Pharmaceutical files $30 million stock, preferreds, debt shelf

By Devika Patel

Knoxville, Tenn., Oct. 7 - Raptor Pharmaceutical Corp. filed a $30 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, debt securities, warrants and units.

The securities may be structured as convertibles.

Proceeds will be used for general corporate purposes.

Raptor is a Novato, Calif., biotechnology company that bioengineers novel drugs and drug-targeting platforms derived from the human receptor-associated protein and related proteins.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.